Seroatlas · Human Serome Atlas

G6PD

Glucose-6-phosphate 1-dehydrogenase

Also known as: G6PD_HUMAN, G6PD1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P11413
Gene
G6PD
Ensembl
ENSG00000160211
Chromosome
X
Canonical length
515 aa
Protein class
Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Centriolar satellite,Cytosol
Quaternary structure
Homotetramer

OverviewNCBI Gene

This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

515 residues, UniProt reviewed canonical sequence.

>P11413|G6PD
     1  MAEQVALSRT QVCGILREEL FQGDAFHQSD THIFIIMGAS GDLAKKKIYP TIWWLFRDGL
    61  LPENTFIVGY ARSRLTVADI RKQSEPFFKA TPEEKLKLED FFARNSYVAG QYDDAASYQR
   121  LNSHMNALHL GSQANRLFYL ALPPTVYEAV TKNIHESCMS QIGWNRIIVE KPFGRDLQSS
   181  DRLSNHISSL FREDQIYRID HYLGKEMVQN LMVLRFANRI FGPIWNRDNI ACVILTFKEP
   241  FGTEGRGGYF DEFGIIRDVM QNHLLQMLCL VAMEKPASTN SDDVRDEKVK VLKCISEVQA
   301  NNVVLGQYVG NPDGEGEATK GYLDDPTVPR GSTTATFAAV VLYVENERWD GVPFILRCGK
   361  ALNERKAEVR LQFHDVAGDI FHQQCKRNEL VIRVQPNEAV YTKMMTKKPG MFFNPEESEL
   421  DLTYGNRYKN VKLPDAYERL ILDVFCGSQM HFVRSDELRE AWRIFTPLLH QIELEKPKPI
   481  PYIYGSRGPT EADELMKRVG FQYEGTYKWV NPHKL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against G6PD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.24
Highest tissue expression
79 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 79 nTPM
  • testis: 75 nTPM
  • esophagus: 69 nTPM
  • adrenal gland: 61 nTPM
  • blood vessel: 49 nTPM
  • pituitary gland: 48 nTPM

Single-cell type

  • oocytes: 193 nCPM
  • esophageal suprabasal cells: 164 nCPM
  • platelets: 160 nCPM
  • neutrophil progenitors: 148 nCPM
  • neutrophils: 141 nCPM
  • megakaryocytes: 136 nCPM

Immune cell

  • eosinophil: 383 nTPM
  • basophil: 154 nTPM
  • neutrophil: 127 nTPM
  • classical monocyte: 76 nTPM
  • NK-cell: 66 nTPM
  • total PBMC: 65 nTPM

Brain region

  • thalamus: 41 nTPM
  • medulla oblongata: 39 nTPM
  • pons: 36 nTPM
  • cerebral cortex: 33 nTPM
  • hypothalamus: 33 nTPM
  • midbrain: 32 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about G6PD.

Disease | AllUniProt

Conditions G6PD is implicated in, by any mechanism.

Disease | GeneticClinVar

230 pathogenic / likely-pathogenic of 875 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.32
gnomAD pLI
0.97
gnomAD missense Z
2
DepMap mean gene effect
-0.15
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of G6PD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads G6PD as an antibody target. Whether an autoantibody or antibody against G6PD could matter depends on whether native G6PD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

G6PD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label G6PD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/G6PD. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...